How Molecular Biomarkers Have Impacted Cancer Treatment

Geoffrey R. Oxnard, MD; Lauren L. Ritterhouse, MD, PhD

Video Categories: PMO Interview with the Innovator Series: Volume 12 and Video Library

Drs Geoffrey Oxnard and Lauren Ritterhouse discuss the challenges and opportunities of precision medicine and molecular biomarkers in their clinical practice from an oncologist’s and a pathologist’s perspective.

April 14, 2015

The bioT3 Platform

Dr. Boccia describes the components of the bioT3 platform and its clinical utility in identifying tumor type and actionable targets for therapy.

September 7, 2018

Working Together to Find the New Standard of Care

Dr Andrey Antov values the benefits of working within an interdisciplinary team to advance cancer care and help patients.